This 56th issue of the Foundation’s newsletter describes two aspects that are of increasing importance in pharmacological research and neurological practice: the repositioning/repurposing of existing medications for the treatment of MS (Prof. Muccioli), and the use of telemedicine to monitor and measure the progression of clinical symptoms (Prof. Nagels and his team).

Download it here